Diretriz da OMS sobre drogas para Covid-19 – Bloqueadores do receptor da interleucina-6 agora são recomendados para pacientes com Covid-19 grave ou crítica.
7 Jul, 2021 | 08:14hA living WHO guideline on drugs for covid-19 – The BMJ
Comentário no Twitter
The latest version of this @WHO living guidance provides a strong recommendation for interleukin-6 (IL-6) receptor blockers (tocilizumab or sarilumab) in patients with severe or critical covid-19. Read the updated WHO guideline on drugs for #COVID19 https://t.co/FUb9yzFRwo
— The BMJ (@bmj_latest) July 6, 2021